logo

Knight Therapeutics Inc. (GUD.TO)



Trade GUD.TO now with
  Date
  Headline
4/23/2018 6:39:56 AM RBC Capital Markets Starts Knight Therapeutics Inc. (GUD.TO) At Outperform With C$9.5 Price Target
3/15/2018 6:08:25 AM Knight Therapeutics Q4 Net Income C$7K Or C$0.05/Shr Vs C$8K Or C$0.06/Shr Last Eyar
3/13/2018 8:04:33 AM Knight Therapeutics Announces Acquisition And Disposition Of Securities Of Crescita Therapeutics
  
 
>